Found 25 matching trials
Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women PHASE2 Preliminary research has shown that a vaginal gel containing the antiretrov...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study to Treat Bacterial Vaginosis PHASE3 The purpose of this study is to determine if product 55394 is safe and effi...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV PHASE2 This phase IIb, two-arm, double-blinded, randomised, placebo controlled tri...
Show More Location
CAPRISA eThekwini Clinical Research Site
Learn More & Join Trial
Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use PHASE1 The purpose of the study is to examine the effects of two contraceptive met...
Show More Location
University of Pittsburgh School of Medicine, Center for Family Planning Research
Learn More & Join Trial
Sexual Absorption of Vaginal Progesterone PHASE4 The purpose of this study is to determine if sexual intercourse lowers seru...
Show More Location
Carolinas Medical Center
Learn More & Join Trial
Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females PHASE1 The purpose of this trial is to assess the safety and acceptability of Teno...
Show More Location
Albert Einstein College of Medicine
Learn More & Join Trial
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms PHASE1 The purpose of this study is to develop markers for use of placebo vaginal ...
Show More Location
Eastern Virginia Medical School
Learn More & Join Trial
PKB171 Against Placebo in Couples With Asthenozoospermia Who Wish to Conceive PHASE2 The test medication Gel PKB171 is a vaginal gel that has not yet been licen...
Show More Location
José Maria Palacios
Learn More & Join Trial
Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy PHASE2 A Phase 2, Dose-ranging, 12-week Randomized, Double-blind, Placebo controll...
Show More Location
For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U
Learn More & Join Trial
A Safety Study Of The Caya® Diaphragm Used With ContraGel® PHASE1 The purpose of this study is to evaluate the safety of ContraGel versus the...
Show More Location
Eastern Virginia Medical School
Learn More & Join Trial